SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-22-213173
Filing Date
2022-08-05
Accepted
2022-08-05 08:14:43
Documents
4
Group Members
HIBERNIA MERGER SUB, INC.IPSEN BIOPHARMACEUTICALS, INC.IPSEN PHARMA SAS

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d377026dsctota.htm SC TO-T/A 34689
2 EX-99.(A)(5)(D) d377026dex99a5d.htm EX-99.(A)(5)(D) 12114
3 GRAPHIC g377026g0803044848893.jpg GRAPHIC 3537
4 GRAPHIC g377026g0803044849080.jpg GRAPHIC 1986
  Complete submission text file 0001193125-22-213173.txt   56329
Mailing Address 42, RUE DU DOCTEUR BLANCHE PARIS I0 75016
Business Address 42, RUE DU DOCTEUR BLANCHE PARIS I0 75016 011 33144961010
Ipsen, S.A. (Filed by) CIK: 0001370483 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-T/A

Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Subject) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-87481 | Film No.: 221138682
SIC: 2834 Pharmaceutical Preparations